Cannara Biotech Inc. announced the appointment of Barry Laxer as Cannara's new Chief Operating Officer, effective August 14, 2019. Barry is a successful business leader that brings over 25 years of experience of leading large-scale operations both domestically and internationally. Barry will replace Evan Morris, who has helped bring the construction phase of Farnham facility to completion.